Effect of Raphia hookeri Seed Extract on Blood Glucose, Glycosylated Haemoglobin and Lipid Profile of Alloxan Induced Diabetic Rats
G. O. Mbaka, S. O. Ogbonnia, K. J. Oyeniran, P. I. Awopetu
Journal of Advances in Medicine and Medical Research · pp. 621–635 · Published 30 Oct 2012
10.9734/BJMMR/2012/1468Abstract
Aim: To examine the effect of Raphia hookeri (RH) seed extract on blood glucose, glycosylated haemoglobin and lipid profile of alloxan induced diabetic rats. Materials and Methods: In the oral glucose tolerance test (OGTT), the animals received the extract (1 g/kg) or glibenclamide (0.01 mg/kg) or vehicle and 30 min later they received oral glucose load (1 g/kg). Glucose was estimated at 30min, 1, 2, 3 and 4 h. In hypoglycaemic study, the extract was administered at doses of 100, 250 and 500 mg/kg body weight (bwt) doses. In fasting blood glucose study (FBG), diabetic Wister rats, 5 per group, received graded doses (50, 100 and 200 mg/kg) of the extract or glibenclamide (10 mg/kg) or vehicle for 15 days. Blood was collected on days 0, 3, 5, 7, 9, 11, 13, 15 for glucose estimation. Lipid profile was analyzed using modified enzymatic procedure. Insulin assay was done by Diagnostic Automation Kit and HbA1C by standard protocol. The studies lasted for three weeks. Results: The diabetic animals treated with the extract showed appreciable weight gain. In oral glucose tolerance test (OGTT), RH seed extract and glibenclamide treated rats blood glucose significantly (P<0.05) decreased in the peak values and the area under curve after 4 h of oral load with decreased values of 48.3±1.0 mg/dL (63.3%) and 62.0±0.8 mg/dL (51.6%) respectively. The hypoglycaemic activity at 250 and 500 mg/kg body weight (bwt) doses showed lowest plasma glycaemic decrease of 50.1% and 54.4% respectively after 8 h of oral administration. In FBG study, after 15 days of extract/glibenclamide treatment, the animals’ blood glucose exacerbated by alloxan challenge returned to normal glycaemia with glycaemic decrease of 87.2±2.3 (79.3%); 57.0±1.7 (86.3%) and 55.0±0.3 mg/dL (87.1%) respectively while glibenclamide showed a maximum glycaemic decrease of 167.4±1.1 mg/dL (60.1%). The tissue morphology of the extract treated showed significant beta cells survivor. The extract ameliorated dislipidaemia and exerted significant (p<0.05) decrease in plasma HbA1C while marked increase in plasma insulin level occurred. Conclusion: The extract effectively attenuated hyperglycaemia, caused marked decrease in HbAIC concentration and ameliorated dislipidaemia.
Cited by 5
Ajeet Singh, Bikarma Singh, Ankita Gautam · Coronavirus Drug Discovery · 2022
Felix A. Dada, Sunday I. Oyeleye, Opeyemi B. Ogunsuyi · Journal of Traditional and Complementary Medicine · 2017
Abimbola Oluyori, Charity Aremu, Charles O. Nwonuma · Tropical Journal of Natural Product Research · 2026
Abdulfatai Ojewale, Sanusi Mada, Samson Oyebadejo · BioMed Research International · 2020
Abdulwakeel Ayokun-nun Ajao, Annah N. Moteetee, Saheed Sabiu · South African Journal of Botany · 2021
Related research
- In Vitro Antioxidant and In Vivo Antidiabetic Properties of Citrus Maxima Leaf Extracts in Alloxan-Induced Swiss Albino Diabetic Mice — shares topic coverage
- Chronic Use of Hormonal Contraceptives and Its Impact on Cardiovascular Risk — shares topic coverage
- Evaluation of Triglyceride to High-Density Lipoprotein Cholesterol Ratio and Atherogenic Indices in Gestational Diabetes Mellitus — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
5
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.